BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26191173)

  • 1. TIGAR overexpression diminishes radiosensitivity of parotid gland fibroblast cells and inhibits IR-induced cell autophagy.
    Tai G; Zhang H; Du J; Chen G; Huang J; Yu J; Cai J; Liu F
    Int J Clin Exp Pathol; 2015; 8(5):4823-9. PubMed ID: 26191173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport.
    Zhang Y; Chen F; Tai G; Wang J; Shang J; Zhang B; Wang P; Huang B; Du J; Yu J; Zhang H; Liu F
    Sci Rep; 2017 Mar; 7():42928. PubMed ID: 28338004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells.
    Peña-Rico MA; Calvo-Vidal MN; Villalonga-Planells R; Martínez-Soler F; Giménez-Bonafé P; Navarro-Sabaté À; Tortosa A; Bartrons R; Manzano A
    Radiother Oncol; 2011 Oct; 101(1):132-9. PubMed ID: 21864926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
    Sinha S; Ghildiyal R; Mehta VS; Sen E
    Cell Death Dis; 2013 May; 4(5):e615. PubMed ID: 23640457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of intracellular ROS levels by TIGAR controls autophagy.
    Bensaad K; Cheung EC; Vousden KH
    EMBO J; 2009 Oct; 28(19):3015-26. PubMed ID: 19713938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization of glioma cells by TP53-induced glycolysis and apoptosis regulator knockdown is dependent on thioredoxin-1 nuclear translocation.
    Zhang H; Gu C; Yu J; Wang Z; Yuan X; Yang L; Wang J; Jia Y; Liu J; Liu F
    Free Radic Biol Med; 2014 Apr; 69():239-48. PubMed ID: 24509157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
    Wanka C; Steinbach JP; Rieger J
    J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIGAR impedes compression-induced intervertebral disc degeneration by suppressing nucleus pulposus cell apoptosis and autophagy.
    Li Z; Shao Z; Chen S; Huang D; Peng Y; Chen S; Ma K
    J Cell Physiol; 2020 Feb; 235(2):1780-1794. PubMed ID: 31317559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells.
    Li L; Liu W; Sun Q; Zhu H; Hong M; Qian S
    Oxid Med Cell Longev; 2021; 2021():8877460. PubMed ID: 33532040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIGAR knockdown enhanced the anticancer effect of aescin via regulating autophagy and apoptosis in colorectal cancer cells.
    Li B; Wang Z; Xie JM; Wang G; Qian LQ; Guan XM; Shen XP; Qin ZH; Shen GH; Li XQ; Gao QG
    Acta Pharmacol Sin; 2019 Jan; 40(1):111-121. PubMed ID: 29769743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy.
    Kumar B; Iqbal MA; Singh RK; Bamezai RN
    Biochimie; 2015 Nov; 118():26-35. PubMed ID: 26212201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
    J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIGAR reduces smooth muscle cell autophagy to prevent pulmonary hypertension.
    Yamanaka R; Hoshino A; Fukai K; Urata R; Minami Y; Honda S; Fushimura Y; Hato D; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1087-H1096. PubMed ID: 32946259
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.
    Yin L; Kosugi M; Kufe D
    Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death.
    Cheung EC; Ludwig RL; Vousden KH
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20491-6. PubMed ID: 23185017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide.
    Maurer GD; Heller S; Wanka C; Rieger J; Steinbach JP
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30823646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIGAR alleviates ischemia/reperfusion-induced autophagy and ischemic brain injury.
    Zhang DM; Zhang T; Wang MM; Wang XX; Qin YY; Wu J; Han R; Sheng R; Wang Y; Chen Z; Han F; Ding Y; Li M; Qin ZH
    Free Radic Biol Med; 2019 Jun; 137():13-23. PubMed ID: 30978385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIGAR has a dual role in cancer cell survival through regulating apoptosis and autophagy.
    Xie JM; Li B; Yu HP; Gao QG; Li W; Wu HR; Qin ZH
    Cancer Res; 2014 Sep; 74(18):5127-38. PubMed ID: 25085248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells.
    Ma T; Zhang Y; Zhang C; Luo JG; Kong LY
    Biochem Pharmacol; 2017 Nov; 143():90-106. PubMed ID: 28774732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of TP53-induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.
    Toshida K; Itoh S; Iseda N; Izumi T; Yoshiya S; Toshima T; Ninomiya M; Iwasaki T; Oda Y; Yoshizumi T
    Cancer Sci; 2024 Jan; 115(1):170-183. PubMed ID: 37878531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.